Cargando…

Genetically Predicted Circulating Level of C-Reactive Protein Is Not Associated With Prostate Cancer Risk

BACKGROUND: Inconsistent findings from observational studies have reported that C-reactive protein (CRP) is likely associated with risk of prostate cancer. Because conventional observational studies are susceptible to confounding and reverse causality, it remains unclear whether there is a causal re...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Chiyu, Qian, Yu, Liu, Bin, Yang, Shaoxue, Ye, Ding, Sun, Xiaohui, Chen, Tianhui, Mao, Yingying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7591790/ https://www.ncbi.nlm.nih.gov/pubmed/33178578 http://dx.doi.org/10.3389/fonc.2020.545603

Ejemplares similares

Genetically Predicted Circulating Concentrations of Alanine and Alanine Aminotransferase Were Associated with Prostate Cancer Risk
por: Yang, Shaoxue, et al.
Publicado: (2022)

Genetically predicted iron status was associated with the risk of prostate cancer
por: Ying, Jiacheng, et al.
Publicado: (2022)

Genetically Predicted Circulating Levels of Cytokines and the Risk of Cancer
por: Song, Jie, et al.
Publicado: (2022)

Genetically Determined Circulating Levels of Cytokines and the Risk of Rheumatoid Arthritis
por: Qian, Yu, et al.
Publicado: (2022)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Associations of the circulating levels of cytokines with risk of amyotrophic lateral sclerosis: a Mendelian randomization study
por: Liu, Bin, et al.
Publicado: (2023)

The potential of using circulating tumour cells and their gene expression to predict docetaxel response in metastatic prostate cancer
por: Davies, Caitlin R., et al.
Publicado: (2023)

Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
por: Bidarra, David, et al.
Publicado: (2019)

Isolation and characterization of circulating tumor cells in prostate cancer
por: Diamond, Elan, et al.
Publicado: (2012)

DNA repair deficiency as circulating biomarker in prostate cancer
por: Catalano, Martina, et al.
Publicado: (2023)

Circulating Vitamin D Levels and Risk of Vitiligo: Evidence From Meta-Analysis and Two-Sample Mendelian Randomization
por: Song, Jie, et al.
Publicado: (2021)

Combination of C-reactive protein/albumin ratio and time to castration resistance enhances prediction of prognosis for patients with metastatic castration-resistant prostate cancer
por: Mitsui, Yozo, et al.
Publicado: (2023)

Predictive value of C-reactive protein levels for the early and later detection of postoperative complications after cytoreductive surgery and HIPEC
por: Roux, Alexia, et al.
Publicado: (2022)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Clinical Significance of Mesenchymal Circulating Tumor Cells in Patients With Oligometastatic Hormone-Sensitive Prostate Cancer Who Underwent Cytoreductive Radical Prostatectomy
por: Yang, Guanjie, et al.
Publicado: (2022)

Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles
por: Pan, Feixia, et al.
Publicado: (2019)

Genetically predicted levels of folate, vitamin B(12), and risk of autoimmune diseases: A Mendelian randomization study
por: Yang, Hong, et al.
Publicado: (2023)

Machine learning model for the prediction of prostate cancer in patients with low prostate-specific antigen levels: A multicenter retrospective analysis
por: Deng, Xiaobin, et al.
Publicado: (2022)

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers
por: Ried, Karin, et al.
Publicado: (2020)

Genetically Predicted C-Reactive Protein Associated With Postmenopausal Breast Cancer Risk: Interrelation With Estrogen and Cancer Molecular Subtypes Using Mendelian Randomization
por: Jung, Su Yon, et al.
Publicado: (2021)

High-risk multiple myeloma predicted by circulating plasma cells and its genetic characteristics
por: Xia, Yuan, et al.
Publicado: (2023)

Age and Prostate-Specific Antigen Level Prior to Diagnosis Predict Risk of Death from Prostate Cancer
por: MacKintosh, F. Roy, et al.
Publicado: (2016)

A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy
por: Mao, Chenyu, et al.
Publicado: (2021)

Genetically Predicted Cigarette Smoking in Relation to Risk of Polycystic Ovary Syndrome
por: Tao, Yingli, et al.
Publicado: (2021)

Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients
por: Qian, Chengcheng, et al.
Publicado: (2021)

C-Reactive Protein Is a Poor Marker of Baseline Inflammation in Prostate Cancer and Response to Radiotherapy or Androgen Ablation
por: Jensen, Garrett L, et al.
Publicado: (2021)

Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer
por: Lian, Shenyi, et al.
Publicado: (2021)

Dynamic changes in PSA levels predict prognostic outcomes in prostate cancer patients undergoing androgen -deprivation therapy: A multicenter retrospective analysis
por: Hu, Mingqiu, et al.
Publicado: (2023)

Baseline Serum C-Reactive Protein and Plasma Fibrinogen-Based Score in the Prediction of Survival in Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2021)

Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer
por: Cheng, Hao, et al.
Publicado: (2022)

The Potential Diagnostic and Prognostic Value of Circulating MicroRNAs in the Assessment of Patients With Prostate Cancer: Rational and Progress
por: Samami, Elham, et al.
Publicado: (2022)

Towards clinical implementation of circulating tumor DNA in metastatic prostate cancer: Opportunities for integration and pitfalls to interpretation
por: Kwan, Edmond M., et al.
Publicado: (2022)

Androgen Receptor Signaling in the Development of Castration-Resistant Prostate Cancer
por: Feng, Qin, et al.
Publicado: (2019)

Prognostic role of preoperative lymphocyte/C-reactive protein associated with upper gastrointestinal cancer: a meta-analysis
por: Ye, Yongjuan, et al.
Publicado: (2023)

Circulating Genetically Abnormal Cells Add Non-Invasive Diagnosis Value to Discriminate Lung Cancer in Patients With Pulmonary Nodules ≤10 mm
por: Ye, Maosong, et al.
Publicado: (2021)

Clinical Implications of Nadir Serum Prostate-Specific Antigen Levels After Transurethral Enucleation of the Prostate
por: Cheng, Yung-Ting, et al.
Publicado: (2022)

Modified Prostate Health Index Density Significantly Improves Clinically Significant Prostate Cancer (csPCa) Detection
por: Chen, Haojie, et al.
Publicado: (2022)

Effects of Radiotherapy or Radical Prostatectomy on the Risk of Long-Term Heart-Specific Death in Patients With Prostate Cancer
por: Guo, Yadong, et al.
Publicado: (2020)

Preoperative Folate Receptor-Positive Circulating Tumor Cell Level Is a Prognostic Factor of Long Term Outcome in Non-Small Cell Lung Cancer Patients
por: Li, Hang, et al.
Publicado: (2021)

Partial Nephrectomy Versus Radical Nephrectomy for Clinical T2 or Higher Stage Renal Tumors: A Systematic Review and Meta-Analysis
por: Huang, Ruizhen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bir30plh804kqfbcl15ppbdevu